BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26308588)

  • 1. Residential treatment outcomes for adolescents with obsessive-compulsive disorder.
    Leonard RC; Franklin ME; Wetterneck CT; Riemann BC; Simpson HB; Kinnear K; Cahill SP; Lake PM
    Psychother Res; 2016 Nov; 26(6):727-36. PubMed ID: 26308588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of specialized residential treatment for adults with obsessive-compulsive disorder.
    Björgvinsson T; Hart AJ; Wetterneck C; Barrera TL; Chasson GS; Powell DM; Heffelfinger S; Stanley MA
    J Psychiatr Pract; 2013 Sep; 19(5):429-37. PubMed ID: 24042250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders.
    Simpson HB; Wetterneck CT; Cahill SP; Steinglass JE; Franklin ME; Leonard RC; Weltzin TE; Riemann BC
    Cogn Behav Ther; 2013; 42(1):64-76. PubMed ID: 23316878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of depression on the treatment of OCD in a residential sample.
    Wetterneck CT; Leonard RC; Adams TG; Riemann BC; Grau P; Franklin ME
    Bull Menninger Clin; 2020 Oct; 84(Supplement A):12-33. PubMed ID: 33074022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of acute outcomes for intensive residential treatment of obsessive-compulsive disorder.
    Siwiec SG; Riemann BC; Lee HJ
    Clin Psychol Psychother; 2019 Nov; 26(6):661-672. PubMed ID: 31273851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How willing are you? Willingness as a predictor of change during treatment of adults with obsessive-compulsive disorder.
    Reid AM; Garner LE; Van Kirk N; Gironda C; Krompinger JW; Brennan BP; Mathes BM; Monaghan SC; Tifft ED; André MC; Cattie J; Crosby JM; Elias JA
    Depress Anxiety; 2017 Nov; 34(11):1057-1064. PubMed ID: 28715850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
    van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
    J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD).
    Højgaard DRMA; Schneider SC; La Buissonnière-Ariza V; Kay B; Riemann BC; Jacobi D; Eken S; Lake P; Nadeau J; Goodman WK; McIngvale E; Storch EA
    Cogn Behav Ther; 2020 Jul; 49(4):294-306. PubMed ID: 31203735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of cognitive-behavioral therapy in children and adolescents with obsessive-compulsive disorders treated in an outpatient clinic].
    Beig I; Döpfner M; Goletz H; Plück J; Dachs L; Kinnen C; Walter D
    Z Kinder Jugendpsychiatr Psychother; 2017; 45(3):219-235. PubMed ID: 27058836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between obsessive-compulsive disorder, depression and functioning before and after exposure and response prevention therapy.
    Motivala SJ; Arellano M; Greco RL; Aitken D; Hutcheson N; Tadayonnejad R; O'Neill J; Feusner JD
    Int J Psychiatry Clin Pract; 2018 Mar; 22(1):40-46. PubMed ID: 28691550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for successful implementation of exposure and response prevention in a naturalistic group format for pediatric OCD.
    Olino TM; Gillo S; Rowe D; Palermo S; Nuhfer EC; Birmaher B; Gilbert AR
    Depress Anxiety; 2011 Apr; 28(4):342-8. PubMed ID: 21456041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Exposure and Response Prevention Behaviorally Activate Patients With Obsessive-Compulsive Disorder? A Preliminary Test.
    Blakey SM; Abramowitz JS; Leonard RC; Riemann BC
    Behav Ther; 2019 Jan; 50(1):214-224. PubMed ID: 30661561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
    Melchior K; Franken I; Deen M; van der Heiden C
    Trials; 2019 May; 20(1):277. PubMed ID: 31109349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are all safety behaviours created equal? A comparison of novel and routinely used safety behaviours in obsessive-compulsive disorder.
    Levy HC; Radomsky AS
    Cogn Behav Ther; 2016 Sep; 45(5):367-79. PubMed ID: 27243978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirically-derived response trajectories of intensive residential treatment in obsessive-compulsive disorder: A growth mixture modeling approach.
    Falkenstein MJ; Nota JA; Krompinger JW; Schreck M; Garner LE; Potluri S; Van Kirk N; Ponzini G; Tifft E; Brennan BP; Mathes B; Cattie J; Crosby JM; Elias JA
    J Affect Disord; 2019 Feb; 245():827-833. PubMed ID: 30699866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.
    Stewart SE; Yen CH; Stack DE; Jenike MA
    J Psychiatr Res; 2006 Sep; 40(6):511-9. PubMed ID: 16229857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of intensive treatment services for obsessive compulsive disorder: outcomes from the first Canadian residential treatment program.
    Taube-Schiff M; Rector NA; Larkin P; Mehak A; Richter MA
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):59-67. PubMed ID: 31670999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.